Prognostic significance of liver metastases as first site of generalisation in patients with breast cancer - A retrospective analysis

Acta Medica Austriaca

Volumn 28, Issue 5, 2001, Pages 135-140

  Baur, Martina ^a   Schlappack, O ^a   Havelec, L ^a   Wrba, F ^a   Dittrich, C ^a  

^a KAISER FRANZ JOSEF HOSPITAL   (Austria)

Author keywords

Lung metastases; Metastatic breast cancer; Primary liver metastases; Prognostic factors

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HORMONE RECEPTOR; LACTATE DEHYDROGENASE;

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BREAST CARCINOMA; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER METASTASIS; MAJOR CLINICAL STUDY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL TIME;

BREAST NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; NEOPLASM METASTASIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0035552152     PISSN: 03038173     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1563-2571.2001.01033.x     Document Type: Article

References (34)

1. Prognostic factors in recurrent breast cancer: Relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading
2. Oestrogen-receptor status and sites of metastasis in breast cancer
3. Patterns of recurrence in Western and Japanese women with breast cancer
4. Combination versus sequential single agent chemotherapy in advanced breast cancer: Associations with metastatic sites and long-term survival
5. Survival from first recurrence: Relative importance of prognostic factors in 1, 015 breast cancer patients
6. The clinical course of bone metastases from breast cancer
7. The diagnosis of breast cancer
8. Prognostic factors in metastatic breast cancer
9. Breast liver metastases - Incidence, diagnosis and outcome
10. Breaking the cure barrier
11. Treatment of breast cancer
12. Evaluation of prognostic factors for 233 patients with recurrent advanced breast cancer
13. Incidence and methodologic aspects of the occurrence of liver metastases in recurrent breast cancer
14. Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence
15. Regionale therapie von isolierten mammakarzinom-lebermetastasen
16. A phase 1/I trial comparing doxorubicin (A) and docetaxel (T) (AT) to doxorubicin and cyclophosphamide (AC) as first line chemotherapy for MBC
17. Liver metastases from breast cancer: The relationship between clinical, biochemical and pathological features and survival
18. Clinical staging and its prognostic significance
19. Combination therapy with trastuzumab (Herceptin) and cisplatin for chemoresistant metastatic breast cancer: Evidence for receptor-enhanced chemosensitivity
20. Palliative therapiefütrung zur hemmung der tumorprogression bei patientinnen mit metastasierten mammakarzinomen
21. Oestrogen receptors and the pattern of relapse in breast cancer
22. Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapy
23. The metastasis-free interval following curative treatment for breast cancer
24. Prognostic significance of disease-free interval
25. The clinical course of lung metastases from breast cancer
26. Der einfluß verschiedener faktoren auf das überleben des rezidivierenden und/oder metastasierenden mammakarzinoms
27. Local control and outcome of patients irradiated for isolated chest wall recurrences of breast cancer
28. Prognostic indices in breast cancer
29. Prognostic factors in metastatic breast cancer treated with combination chemotherapy
30. Factors influencing the response and survival of patients with liver metastases from breast cancer receiving OK-432-combined adoptive immunotherapy
31. Die lokoregionale chemotherapie zur behandlung von lebermetastasen des mammakarzinoms
32. Clinical course of breast cancer patients with liver metastases